BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3601255)

  • 1. Mast cell degranulation and glucose homeostasis.
    Nutr Rev; 1987 May; 45(5):152-3. PubMed ID: 3601255
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated blood glucose after compound 48/80 treatment is not related to hepatic mast cell degranulation in rats.
    Dimlich RV; Reilly FD
    Proc Soc Exp Biol Med; 1986 Dec; 183(3):321-7. PubMed ID: 3797416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
    Humphreys RA; Kane KA; Parratt JR
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
    Reilly FD; Cilento EV; McCuskey RS
    Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells.
    Keller AM; Clancy RM; Barr ML; Marboe CC; Cannon PJ
    Circ Res; 1988 Dec; 63(6):1044-52. PubMed ID: 2848639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
    McGregor JA; Levin MJ; Masters H
    J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
    [No Abstract]   [Full Text] [Related]  

  • 10. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
    Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of histamine and serotonin release from rat peritoneal mast cells induced by nerve growth factor and compound 48/80.
    Ferjan I; Carman-Krzan M; Erjavec F
    Inflamm Res; 1997 Mar; 46 Suppl 1():S23-4. PubMed ID: 9098747
    [No Abstract]   [Full Text] [Related]  

  • 13. ["In vivo" immunologic and compound 48-80 degranulation of cutaneous rat mast cells].
    Gisbert M; Queralt J
    Arch Farmacol Toxicol; 1984 Apr; 10(1):39-44. PubMed ID: 6508368
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation of Hageman factor by chymotrypsin-like protease released from rat mast cells during degranulation.
    Majima M; Tani Y; Katori M
    Adv Exp Med Biol; 1989; 247A():487-92. PubMed ID: 2690590
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the question of mast cell degranulation by compound 48-80. Tachyphylaxis of isolated mast cells against 48-80, inhibition of degranulation by heparinoids, modification of tachyphylaxis by protamine].
    Schuster J; Kunze J
    Arzneimittelforschung; 1969 Apr; 19(4):589-91. PubMed ID: 4182108
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects on sympathetic neurotransmission of mast cell degranulation by compound 48/80 or antigen in the rat isolated perfused heart.
    Ries P; Fuder H
    Methods Find Exp Clin Pharmacol; 1994; 16(6):419-35. PubMed ID: 7530791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local degranulation of individual rat peritoneal mast cells induced by compound 48-80.
    Diamant B; Kruger PG; Uvans B
    Acta Physiol Scand; 1970 May; 79(1):1-5. PubMed ID: 5431010
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of mast-cell degranulation by anti-inflammatory agents.
    Yamasaki H; Saeki K
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):166-79. PubMed ID: 6048723
    [No Abstract]   [Full Text] [Related]  

  • 19. Mast cell degranulation is essential for anastomotic healing in well perfused and poorly perfused rat colon.
    Coneely J; Kennelly R; Bouchier-Hayes D; Winter DC
    J Surg Res; 2010 Nov; 164(1):e73-6. PubMed ID: 20828736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anti-ulcer alpha,beta-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation.
    Penissi AB; Vera ME; Mariani ML; Rudolph MI; CeƱal JP; de Rosas JC; Fogal TH; Tonn CE; Favier LS; Giordano OS; Piezzi RS
    Eur J Pharmacol; 2009 Jun; 612(1-3):122-30. PubMed ID: 19344708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.